Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas B Brunner

Showing results (51-60 of 100) with videos related to

Pageof 10
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 28, 2018
Correspondence on Rajyaguru et alJudit Boda-Heggemann, Eleni Gkika, Nicolaus Andratschke, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 2, 2016
The radiosensitizing effects of Nelfinavir on pancreatic cancer with and without pancreatic stellate cellsOsama Al-Assar, Martin-Immanuel Bittner, Serena Lunardi, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 8, 2013
A treatment planning comparison of four target volume contouring guidelines for locally advanced pancreatic cancer radiotherapyEmmanouil Fokas, Cynthia Eccles, Neel Patel, et al.
International Journal of Radiation Oncology, Biology, Physics|December 31, 2002
Phase I trial of strictly time-scheduled gemcitabine and cisplatin with concurrent radiotherapy in patients with locally advanced pancreatic cancerThomas B Brunner, Gerhard G Grabenbauer, Peter Klein, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|September 17, 2009
Downstaging of pancreatic carcinoma after neoadjuvant chemoradiationDominik Tinkl, Gerhard G Grabenbauer, Henriette Golcher, et al.
International Journal of Radiation Oncology, Biology, Physics|July 2, 2005
Definition of elective lymphatic target volume in ductal carcinoma of the pancreatic head based on histopathologic analysisThomas B Brunner, Susanne Merkel, Gerhard G Grabenbauer, et al.
Cancer Research|October 3, 2003
Farnesyltransferase inhibitors: an overview of the results of preclinical and clinical investigationsThomas B Brunner, Stephen M Hahn, Anjali K Gupta, et al.
Cancer Biology & Therapy|September 13, 2008
Stromal SPARC expression and patient survival after chemoradiation for non-resectable pancreatic adenocarcinomaTine S Mantoni, Roy R E Schendel, Franz Rödel, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 1, 2014
Contextual regulation of pancreatic cancer stem cell phenotype and radioresistance by pancreatic stellate cellsOsama Al-Assar, Fevzi Demiciorglu, Serena Lunardi, et al.
Cancer Research|September 17, 2005
Pancreatic cancer cell radiation survival and prenyltransferase inhibition: the role of K-RasThomas B Brunner, Keith A Cengel, Stephen M Hahn, et al.
Pageof 10

Showing results (51-60 of 100) with videos related to

Sort By:
Pageof 10
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 28, 2018
Correspondence on Rajyaguru et alJudit Boda-Heggemann, Eleni Gkika, Nicolaus Andratschke, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 2, 2016
The radiosensitizing effects of Nelfinavir on pancreatic cancer with and without pancreatic stellate cellsOsama Al-Assar, Martin-Immanuel Bittner, Serena Lunardi, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 8, 2013
A treatment planning comparison of four target volume contouring guidelines for locally advanced pancreatic cancer radiotherapyEmmanouil Fokas, Cynthia Eccles, Neel Patel, et al.
International Journal of Radiation Oncology, Biology, Physics|December 31, 2002
Phase I trial of strictly time-scheduled gemcitabine and cisplatin with concurrent radiotherapy in patients with locally advanced pancreatic cancerThomas B Brunner, Gerhard G Grabenbauer, Peter Klein, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|September 17, 2009
Downstaging of pancreatic carcinoma after neoadjuvant chemoradiationDominik Tinkl, Gerhard G Grabenbauer, Henriette Golcher, et al.
International Journal of Radiation Oncology, Biology, Physics|July 2, 2005
Definition of elective lymphatic target volume in ductal carcinoma of the pancreatic head based on histopathologic analysisThomas B Brunner, Susanne Merkel, Gerhard G Grabenbauer, et al.
Cancer Research|October 3, 2003
Farnesyltransferase inhibitors: an overview of the results of preclinical and clinical investigationsThomas B Brunner, Stephen M Hahn, Anjali K Gupta, et al.
Cancer Biology & Therapy|September 13, 2008
Stromal SPARC expression and patient survival after chemoradiation for non-resectable pancreatic adenocarcinomaTine S Mantoni, Roy R E Schendel, Franz Rödel, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 1, 2014
Contextual regulation of pancreatic cancer stem cell phenotype and radioresistance by pancreatic stellate cellsOsama Al-Assar, Fevzi Demiciorglu, Serena Lunardi, et al.
Cancer Research|September 17, 2005
Pancreatic cancer cell radiation survival and prenyltransferase inhibition: the role of K-RasThomas B Brunner, Keith A Cengel, Stephen M Hahn, et al.
Pageof 10